Neoadjuvant chemotherapy in technically unresectable head and neck cancers: a retrospective audit

Abstract

Our study shows that neoadjuvant chemotherapy in technically unresectable HNC patients can make the disease resectable in around one-third of the patients. The patients who could undergo surgery after neoadjuvant chemotherapy had significantly improved survival as compared to those who could not.